| Bid Price | 15.10p | High Price | 16.60p |
|---|
| Ask Price | 16.70p | Low Price | 15.10p |
|---|
| Open Price | 15.10p | Spread | 9.58% |
|---|
| Prev Close | 15.85p | Volume | 6,091 |
|---|
Oncimmune Holdings PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Oct 11, 2024 | 15.10 | 16.60 | 15.10 | 15.90 | 6,091 |
| Oct 10, 2024 | 16.90 | 16.90 | 15.73 | 15.85 | 13,371 |
| Oct 9, 2024 | 15.10 | 15.97 | 15.10 | 15.85 | 1,186 |
| Oct 8, 2024 | 15.60 | 15.60 | 15.14 | 15.70 | 7,170 |
| Oct 7, 2024 | 16.90 | 16.90 | 16.50 | 15.85 | 10,057 |
Oncimmune Holdings PLC Information
| Name | Oncimmune Holdings PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BYQ94H38 | Epic | ONC |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | AMSM |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 15,000 | Trading Status | Closed |
|---|
| Shares in Issue | 74.14 m | Prev Close | 15.85p |
|---|
| PE Ratio | | Market Cap | £11.79 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.135088 | Quick Ratio | 1.008772 |
|---|
Oncimmune Holdings PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 11/12/23 | BUY | Martin Gouldstone | CEO | 36,023 @ £0.27 | £9,816.00 |
| 05/06/23 | BUY | Adam Hill | RES | 48,370 @ £0.21 | £9,990.00 |
| 16/12/22 | PLAC | Alistair Macdonald | CH | 55,555 @ £0.45 | £25,000.00 |
| 16/12/22 | PLAC | Timothy Bunting | RES | 1,900,000 @ £0.45 | £855,000.00 |
| 21/09/22 | BUY | Adam Hill | RES | 8,005 @ £0.62 | £5,000.00 |
| 20/04/22 | EXR | Matthew Hall | FD | 66,330 @ £1.09 | £72,300.00 |
| 20/04/22 | SEXR | Matthew Hall | FD | 78,882 @ £1.26 | £99,391.00 |
| 20/04/22 | EXR | Matthew Hall | FD | 12,552 @ £1.20 | £15,000.00 |
| 29/03/22 | EXR | Matthew Hall | FD | 10,000 @ £1.09 | £10,900.00 |
| 29/03/22 | SEXR | Matthew Hall | FD | 10,000 @ £1.35 | £13,500.00 |
Oncimmune Holdings PLC News
